• Blog
  • Ep Catheter Ablation Market Growth | 2023-2028

    Ep Catheter Ablation Market Growth | 2023-2028

    Ep Catheter Ablation Market Growth | 2023-2028
    Report code - SR1926 Delivery - 2 Weeks
    EP Catheter Ablation Market Size, Share, Trend, Forecast, & Industry Analysis: 2023-20 See more...

    Market Insights

    The ep catheter ablation market is estimated to grow from US$ 2.1 Billion in 2022 to US$ 3.37 Billion in 2028 at a CAGR of 8.28% during the forecast period.

    Ep Catheter Ablation Market Size

    Wish to get a Free Sample? Register here.

    What is ep catheter ablation?

    Electrophysiology (EP) is the branch of cardiology that deals with the diagnosis as well as treatment of heart rhythm disorders. The EP study enables the assessment of electrical impulses of the heart and evaluates abnormal heartbeats. EP ablation is a minimally invasive procedure that employs catheters to destroy faulty electrical pathways in the heart. These devices are useful in the removal of abnormal heart tissues which cause irregular heart rhythms.

    Ep Catheter Ablation Market Report Overview

    Market Size in 2028

    USD 3.37 Billion

    Market Size in 2022

    USD 2.1 Billion

    Market Growth (2023-2028)

    CAGR of 8.28%

    Base Year of Study

    2022

    Trend Period

    2016-2021

    Forecast Period

    2023-2028

    Covid-19 Impact Analysis

    The COVID-19 pandemic has moderately affected the ep catheter ablation industry. Also, social distancing, limited access to clinics, and lockdown of the population, that has led to a slowdown in patient flow & referrals.

    The focus of healthcare professionals has been shifted toward the treatment of COVID-19-infected patients, which affected the treatment of non-emergency medical conditions, amid the pandemic.

    Key Players

    The following are the key players in the ep catheter ablation market -

    • Biosense Webster (US)
    • Abbott Laboratories (US)
    • MEDTRONIC PLC (Ireland)
    • Boston Scientific Corporation (US)
    • CathRx Ltd (Australia)
    • Biotronik SE & Co. KG. (Germany)
    • Japan Lifeline Co (Japan)
    • ATRICURE, INC. (US)
    • Auris Health (US)
    • Biomerics (US)

    Market Dynamics

    The ep catheter ablation market is driven by a host of factors, some of which are noted below:

    • Rising number of diseases that requires endoscopic ultrasound procedures, as well as an increasing geriatric population.
    • Growing testing facilities as well as ongoing technological advancements in the healthcare sector across the globe.
    • Physicians’ preference for ablation procedures has augmented the increased adoption rate of cardiac monitoring devices, during the review period.
    • Growing incidence of cancer cases.

    Ep Catheter Ablation Market Snapshot

    To get the full scope of the report, Register Here.

    Segment Analysis

    Product Trends

    The Market is classified into RF ablation ep catheters, Cryoablation ep catheters, microwave ablation ep catheters, and others.  The RF ablation ep catheters are expected to be dominant in the market during the forecast period. It is the preferred power source for catheter ablation in most EP labs. Alternating current, with a frequency range of 100 to 2000 kHz, is radio frequency energy.

    RF radiation has been used in operating rooms to cauterize small bleeding arteries. Using RF radiation to create a discrete intracardiac lesion is possible by attaching an RF generator to a catheter electrode implanted in the heart.

    Application Trends

    The market has been classified into hospitals, diagnostic centers, and ASCs. The hospital accounted for the largest market share in 2022. This is mainly attributed to the high spending capacity of hospitals on innovative EP products coupled with a large presence of skilled expertise.

    Moreover, the growing number of patient visits to hospitals well-equipped with electrophysiology departments further augments the market growth.

    Regional Analysis

    The North American market accounted for the highest share in 2022 and is expected to grow at a robust CAGR during the review period. The EP Catheter Ablation market growth is mainly attributed to changing lifestyles of the people, rising incidence of lifestyle-associated factors, increasing prevalence of arrhythmias, and unhealthy dietary habits augments the regional market growth during the forecast timeline.

    Ep Catheter Ablation Market By Region

    Want to know which region offers the best growth opportunities, Register Here.

    The Asia Pacific is expected to grow at the healthy CAGR during the review period due to changing lifestyles and eating habits, increasing stress and habitual smoking & drinking in these countries, surging health-related problems such as obesity, heart disease, and other chronic diseases, further bolsters the regional market growth.

    Segmentation

    This report studies the market covering a period of 12 years of trend and forecast. The report provides detailed insights into the market dynamics to enable informed business decision-making and growth strategy formulation based on the opportunities present in the market.

    By Product 

    • RF Ablation EP Catheters
    • Cryoablation EP Catheters
    • Microwave Ablation EP Catheters

    By Application 

    • Hospitals
    • Diagnostic Centres
    • ASCs

    By Region

    • North America (Country Analysis: The USA, Canada, and Mexico)
    • Europe (Country Analysis: Germany, France, The UK, Russia, and the Rest of Europe)
    • Asia-Pacific (Country Analysis: China, India, Australia, South Korea, and the Rest of Asia-Pacific
    • Rest of the World (Country Analysis: Saudi Arabia, Brazil, and Others)

    Report Features

    This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision-making for the existing market players as well as those willing to enter the market.
    What Deliverables Will You Get in this Report?

    Key questions this report answers

    Relevant contents in the report

    How big is the sales opportunity?

    In-depth analysis of the ep catheter ablation market

    How lucrative is the future?

    The market forecast and trend data and emerging trends

    Which regions offer the best sales opportunities?

    Global, regional, and country-level historical data and forecasts

    Which are the most attractive market segments?

    Market segment analysis and Forecast

    Which are the top players and their market positioning?

    Competitive landscape analysis, Market share analysis

    How complex is the business environment?

    Porter’s five forces analysis, PEST analysis, Life cycle analysis

    What are the factors affecting the market?

    Drivers & challenges

    Will I get the information on my specific requirement?

    10% free customization

    Target Audience

    The target audience of the ep catheter ablation market includes-

    • EP Catheter Ablation Vendors
    • EP Catheter Ablation Manufacturers
    • EP Catheter Ablation Distributors
    • Organizations
    • Government Bodies.

    Critical Questions Answered in the Report

    This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the market. The following are the critical questions answered in the report.

    • What are the key trends in the market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the market?
    • What are the key strategies adopted by the major vendors to lead in the market?
    • What is the market share of the top vendors?

    Research Methodology

    This report offers high-quality insights and is the outcome of a detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders, and validation and triangulation with Stratview Research’s internal database and statistical tools.

    More than 1,000 authenticated secondary sources, such as company annual reports, fact books, press releases, journals, investor presentations, white papers, patents, and articles have been leveraged to gather the data.

    We conducted more than 10 detailed primary interviews with the market players across the value chain in all four regions and with industry experts to obtain both qualitative and quantitative insights.

    Customization Option

    Stratview Research offers one of the following free customization options to our respectable clients:

    Company Profiling

    • Detailed profiling of additional market players (up to three players)
    • SWOT analysis of key players (up to three players)

    Competitive Benchmarking

    Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    Electrophysiology (EP) is the branch of cardiology that deals with the diagnosis as well as treatment of heart rhythm disorders. The EP study enables the assessment of electrical impulses of the heart and evaluates abnormal heartbeats. EP ablation is a minimally invasive procedure that employs catheters to destroy faulty electrical pathways in the heart. These devices are useful in the removal of abnormal heart tissues which cause irregular heart rhythms.

    The market is estimated to reach US$ 3.37 Billion in 2028.

    The market was estimated to grow from US$ 2.1 Billion in 2022.

    The market is projected to grow at a CAGR of 8.28% during the forecast period.

    Key players operating in the market are Biosense Webster (US), Abbott Laboratories (US), MEDTRONIC PLC (Ireland), Boston Scientific Corporation (US), CathRx Ltd (Australia), Biotronik SE & Co. KG. (Germany), Japan Lifeline Co (Japan), ATRICURE, INC. (US), Auris Health (US), Biomerics (US).

    The North American market accounted for the largest share in 2022 and is expected to grow at a robust CAGR during the review period.

    The market is primarily propelled by a growing incidence of cancer cases, the rising number of diseases that requires endoscopic ultrasound procedures, as well as an increasing geriatric population.